Clinical Trial Update: Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers [Phase 1]

View source ↗

Summary

This is a completed Phase 1 safety study evaluating a new dosing schedule of capecitabine and docetaxel in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Metastatic Breast Cancer | Phase 1 | Status: COMPLETED